Ilex Medical Ltd (ILX.TA)
- Previous Close
6,105.00 - Open
6,105.00 - Bid 6,052.00 x 10500
- Ask 6,200.00 x 6500
- Day's Range
6,052.00 - 6,347.00 - 52 Week Range
5,643.00 - 8,499.00 - Volume
2,496 - Avg. Volume
5,170 - Market Cap (intraday)
830.495M - Beta (5Y Monthly) 0.02
- PE Ratio (TTM)
15.15 - EPS (TTM)
4.09 - Earnings Date --
- Forward Dividend & Yield 1.22 (2.00%)
- Ex-Dividend Date Apr 7, 2025
- 1y Target Est
--
Ilex Medical Ltd provides healthcare technological solutions in Israel, South Africa, and internationally. The company offers microbiology, chemistry, molecular biology, immunochemistry, and blood banking solutions. It also offers coagulation, hematology, blood gases, bilirubin, biomarkers, fertility, cellular medicine occult blood, and calprotectin services, as well as provides LIS, urine microscopy, osmolarity, and genetic laboratory services. In addition, the company offers medical automation solutions for microbiology, immunoserology, chemistry, hematology, and coagulation. Further, it provides medical equipment, pain management, endoscopy system, digestive health, cardiology, vasuclar interventions, radiology, care wards, radiotherapy, urology, ophtalmology, anesthesia, respiratory care, endoscopy system and digestive health, and woman health services; oncogenetics, pharmacogenetics, and pregnancy check, genetic diseases testing services. Additionally, the company offers single cell analysis, microbiome, epigenetics, gene expression, bioinformatics, molecular diagnostics, automated and manual DNA/RNA, and liquid biopsy solutions. Furthermore, it provides Vento2ux and Flight 60, a clinical ventilation product. Ilex Medical Ltd was founded in 1977 and is based in Petah Tikva, Israel.
www.ilexmedical.comRecent News: ILX.TA
View MorePerformance Overview: ILX.TA
Trailing total returns as of 5/29/2025, which may include dividends or other distributions. Benchmark is TA-125 (^TA125.TA) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ILX.TA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ILX.TA
View MoreValuation Measures
Market Cap
830.49M
Enterprise Value
703.69M
Trailing P/E
14.93
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.74
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
4.24%
Return on Assets (ttm)
3.91%
Return on Equity (ttm)
7.20%
Revenue (ttm)
920.37M
Net Income Avi to Common (ttm)
45.7M
Diluted EPS (ttm)
4.09
Balance Sheet and Cash Flow
Total Cash (mrq)
236.88M
Total Debt/Equity (mrq)
7.94%
Levered Free Cash Flow (ttm)
29.62M